Hepatocellular carcinoma with complete response to the immunotherapy:the oncologist’s dilemma
摘要
Hepatocellular carcinoma(HCC)is the seventh most common cancer and the fourth leading cause of cancer-related death worldwide(1).During the last decade,many efforts have been made to improve patient survival by conducting clinical trials investigating local and systemic treatment options for patients with unresectable tumors.However,despite significant research efforts,only few treatment approaches have been validated for HCC.
参考文献2
-
1Stefano Colagrande,Andrea L Inghilesi,Sami Aburas,Gian G Taliani,Cosimo Nardi,Fabio Marra.challenges of advanced hepatocellular carcinoma[J].World Journal of Gastroenterology,2016,22(34):7645-7659. 被引量：19
-
2刘昊天,钟鉴宏,FINN RS,QIN S,IKEDA M.IMbrave150研究:免疫抑制剂治疗首次取得晚期肝细胞癌一线治疗成功[J].临床肝胆病杂志,2020,36(9):2148-2148. 被引量：523
二级参考文献121
-
1Giuseppe Cabibbo,Marcello Maida,Chiara Genco,Pietro Parisi,Marco Peralta,Michela Antonucci,Giuseppe Brancatelli,Calogero Cammà,Antonio Craxì,Vito Di Marco.untreatable hepatocellular 癌的自然历史: 回顾的队研究[J].World Journal of Hepatology,2012,4(9):256-261. 被引量：11
-
2Alexander J. Thompson,Andrew J. Muir,Mark S. Sulkowski,Dongliang Ge,Jacques Fellay,Kevin V. Shianna,Thomas Urban,Nezam H. Afdhal,Ira M. Jacobson,Rafael Esteban,Fred Poordad,Eric J. Lawitz,Jonathan McCone,Mitchell L. Shiffman,Greg W. Galler,William M. Lee,Robert Reindollar,John W. King,Paul Y. Kwo,Reem H. Ghalib,Bradley Freilich,Lisa M. Nyberg,Stefan Zeuzem,Thierry Poynard,David M. Vock,Karen S. Pieper,Keyur Patel,Hans L. Tillmann,Stephanie Noviello,Kenneth Koury,Lisa D. Pedicone,Clifford A. Brass,Janice K. Albrecht,David B. Goldstein,John G. McHutchison.Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus[J]. Gastroenterology . 2010 (1)
-
3Llovet Josep M,Ricci Sergio,Mazzaferro Vincenzo,Hilgard Philip,Gane Edward,Blanc Jean-Frédéric,de Oliveira Andre Cosme,Santoro Armando,Raoul Jean-Luc,Forner Alejandro,Schwartz Myron,Porta Camillo,Zeuzem Stefan,Bolondi Luigi,Greten Tim F,G.Sorafenib in advanced hepatocellular carcinoma. The New England Quarterly . 2008
-
4B Taouli,DM Koh.Diffusion-weighted MR imaging of the liver. Radiology . 2010
-
5Pugh R N,Murray-Lyon I M,Dawson J L,Pietroni M C,Williams R.Transection of the oesophagus for bleeding oesophageal varices. The British journal of surgery . 1973
-
6Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncology.2009(1)
-
7Riccardo Lencioni,Josep Llovet.Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma[J].Semin Liver Dis.2010(01)
-
8Shukui Qin,Yuxian Bai,Ho Yeong Lim,Sumitra Thongprasert,Yee Chao,Jia Fan,Tsai-Shen Yang,Vajarabhongsa Bhudhisawasdi,Won Ki Kang,Yu Zhou,Jee Hyun Lee,Yan Sun.Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia[J].Journal of Clinical Oncology.2013(28)
-
9Vincenzi Bruno,Santini Daniele,Russo Antonio,Addeo Raffaele,Giuliani Francesco,Montella Liliana,Rizzo Sergio,Venditti Olga,Frezza Anna Maria,Caraglia Michele,Colucci Giuseppe,Del Prete Salvatore,Tonini Giuseppe.Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib. The Oncologist . 2010
-
10Maria Reig,Ferran Torres,Carlos Rodriguez-Lope,Alejandro Forner,Neus LLarch,Jordi Rimola,Anna Darnell,José Ríos,Carmen Ayuso,Jordi Bruix.Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib[J]. Journal of Hepatology . 2014
共引文献540
-
1陈璐,宋天强,李强.晚期胆道系统肿瘤免疫治疗研究进展[J].中国实用外科杂志,2020(11):1340-1344. 被引量：4
-
2余昌中,金华,安然.肝脏胆囊双原发癌临床病理分析及文献复习[J].诊断病理学杂志,2022,29(9):830-833.
-
3王楠,薛国亮,徐静雯,危志刚,叶欣.微波消融在载药微球经肝动脉化疗栓塞术联合靶向和免疫治疗进展期原发性肝癌中的应用[J].中华肿瘤防治杂志,2023,30(14):865-870. 被引量：2
-
4杨荣,范建高.非酒精性脂肪性肝病相关肝细胞肝癌的研究进展[J].临床内科杂志,2022,39(12):793-796. 被引量：4
-
5Masatoshi Kudo.A new era of systemic therapy for intermediate and advanced stage hepatocellular carcinoma[J].Hepatobiliary Surgery and Nutrition,2020,9(4):530-533.
-
6Di-Yang Xie,Zheng-Gang Ren,Jian Zhou,Jia Fan,Qiang Gao.2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights[J].Hepatobiliary Surgery and Nutrition,2020,9(4):452-463. 被引量：82
-
7付强,刘东伯,沈倩,张孟贤,张莉红,邱红,袁响林.晚期肝细胞癌病人重启免疫治疗的临床疗效[J].中华消化外科杂志,2021,20(S02):45-48. 被引量：3
-
8周闯,叶健文,宋盛平,刘文韬,于龙,薛建锋,赵龙栓,翟文龙.免疫联合靶向治疗原发性肝细胞肝癌合并胆管癌栓术后复发的临床疗效[J].中华消化外科杂志,2021,20(S02):10-14.
-
9董敏,吴东昊,江婷,吴祥元.阿替利珠单克隆抗体联合贝伐珠单克隆抗体一线治疗肝细胞癌术后复发的临床疗效[J].中华消化外科杂志,2021,20(S02):5-9.
-
10曹洪祥,廖锐,贺强,潘龙,赵益,王永琛,黄俊杰,吴晨锐,孙锐睿,黄平.肝动脉灌注化疗联合免疫靶向治疗在晚期肝细胞癌中的临床疗效[J].中华消化外科杂志,2021,20(S02):41-44. 被引量：2
-
1Yingyan Yu.Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers[J].Cancer Biology & Medicine,2021,18(4):944-948. 被引量：2
-
2唐菊灏,沈思怡(指导).团结:希望的力量——《流浪地球》影评[J].疯狂英语（初中天地）,2022(4):59-60.
-
3Yi-Qi Su,Yi-Yi Yu,Bo Shen,Feng Yang,Yu-Xin Nie.Management of acute kidney injury in gastrointestinal tumor:An overview[J].World Journal of Clinical Cases,2021,9(35):10746-10764.
-
4高欣,解海谊,王慧涵,廖爱军.国产与进口硼替佐米治疗多发性骨髓瘤的真实世界疗效、安全性及经济学对比[J].现代肿瘤医学,2022,30(10):1821-1825. 被引量：6
-
5Yi Li,Wei Guo,Xiuqin Li,Jianguo Zhang,Moyi Sun,Zhangui Tang,Wei Ran,Kai Yang,Guilin Huang,Longjiang Li.Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers[J].International Journal of Oral Science,2021,13(4):333-338.
-
6Editorial Office.Erratum to classification of hepatic venous tumor thrombus in hepatocellular carcinoma:should it describe tumor status or predict patient survival?[J].Hepatobiliary Surgery and Nutrition,2022,11(1):173-173.
-
7Siyu Cai,Qiaohong Guo,Xianjing Wang,Ruixin Wang,Peiyi Yang,Yuchen Zhou,Yanhui Luo,Xuan Zhou,Xiaoxia Peng.Development levels of pediatric palliative care teams and the extent of palliative care understanding and implementation among pediatric oncologists in China[J].Pediatric Investigation,2021,5(4):265-270.
-
8林丽珠,王思愚,黄学武.An Expert Consensus of Integrated Chinese and Western Medicine Treatment on Lung Cancer[J].World Journal of Integrated Traditional and Western Medicine,2021,7(6):1-26.
-
9Zi-Ning Liu,Yin-Kui Wang,Li Zhang,Yong-Ning Jia,Shan Fei,Xiang-Ji Ying,Yan Zhang,Shuang-Xi Li,Yu Sun,Zi-Yu Li,Jia-Fu Ji.Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy[J].World Journal of Gastrointestinal Oncology,2021,13(12):2161-2179. 被引量：1
-
10劳峥,石慧烽,毕帆,樊文慧,邵滋旸,涂文勇.眼眶恶性肿瘤综合治疗的疗效和安全性分析(附88例)[J].现代肿瘤医学,2022,30(9):1582-1586.
